Between the Bells
Tune in to the Bell Direct 'Between the Bells' podcast, where we'll cover the latest economic news and updates, market movements and analysis. With daily updates, you can get the information you need to find your investing edge.
Find Bell Direct here:
Website: https://www.belldirect.com.au/smarter/
Twitter: https://twitter.com/belldirect
Facebook: https://www.facebook.com/BellDirectAustralia
LinkedIn: https://www.linkedin.com/company/bell-direct/
Instagram: https://www.instagram.com/bell.direct/
Episodes
1692 episodes
Weekly Wrap 3 July
Markets were mixed last week, with the US and Europe rising while Japan, emerging markets, and the ASX slipped. This week, Max Lo Certo speaks with Bell Potter's Lead Strategist Rob Crookston to examine the key forces shaping recent market move...
Weekly Wrap 12 June
This week's markets were shaped by a tug-of-war between Middle East tensions and Trump-led de-escalation, leaving US equities broadly flat but the ASX finishing the week stronger. Domestically, the picture was mixed - bank stocks came under fur...
Weekly Wrap 5 June
The ASX saw a strong week this week, bouncing over 1% and outpacing global equities. Today, Sophia Mavridis sits down with Bell Financial Group’s CIO Will Riggall to unpack the macroeconomic factors that moved the markets recently, the surging ...
Weekly Wrap 22 May
Bell Potter’s Lead Strategist Rob Crookston talks what’s driving markets right now in this week’s wrap. The bond markets lead the way while equities followed this week, while economic news is back in focus.In this week’s wrap, Rob and So...
Weekly Wrap 15 May
: Markets were pulled in two directions this week as Australia’s federal budget weighed on banks and property-linked stocks, while strong US earnings and booming AI demand pushed global markets higher. In this week’s interview, Bell Financial G...
From the helm: Solstice Minerals (ASX:SLS), Managing Director and CEO Nick Castleden
In this episode of From the Helm, Solstice Minerals Managing Director and CEO Nick Castleden joins us to discuss the company’s exploration progress and the growing momentum behind its flagship Nanadie copper-gold project.Nick pr...
Weekly Wrap 8 May
We saw another week of major moves on the market last week, as continuing volatility in oil prices and the RBA’s 25 basis point rate increase dominated the headlines. Today, Sophia Mavridis was joined by Bell Financial Group’s CIO Will Riggall ...
Weekly Wrap 1 May
Strong earnings and a resilient US economy are pushing Wall Street higher, with Meta and Alphabet leading a massive week of mega-cap reporting. It’s a different story in Australia, as local sectors dipped in April as investors trade cautiously ...
Weekly Wrap 24 April
Market volatility is back on the radar this week as geopolitical tensions drive oil prices higher and keep global investors on edge. While the Wall Street had a strong month driven by the AI sector, the local market is facing a more challenging...
Weekly Wrap 17 April
In this week’s Weekly Wrap, CIO Will Riggall is joined by Bell Potter’s Lead Strategist Rob Crookston to unpack the key drivers behind the recent market rally and what comes next.Despite ongoing geopolitical uncertainty and rising oil pr...
From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon
In this episode of From the helm, Sophia Mavridis is joined by Centaurus Metals (ASX:CTM) CEO & MD Darren Gordon to discuss what sets their product apart from its peers and what is next for the broader nickel market.
From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter
In this episode of From the helm, Sophia Mavridis sits down with Oneview Healthcare (ASX:ONE) CEO James Fitter to unpack their unique end-to-end patient monitoring technology, the impact of AI emergence on their business and what’s to come look...
From the helm: Titomic Ltd, CFO, Geoff Hollis
In this episode of From the helm, Titomic (ASX:TTT) CFO Geoff Hollis joins us for a deep dive into their proprietary technology for the manufacture of metal parts, including how it differentiates from other products in the market and what is on...
From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder
In this episode of From the Helm, John Konstantopoulos, CEO & Co-Founder of Artrya Limited (ASX:AYA), joins us to discuss the company’s AI-powered approach to transforming cardiac diagnostics and improving patient outcomes.John prov...
From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO
In this episode of From the Helm, Arnie Selvarajah, Group Co-CEO of Bell Financial Group (ASX:BFG), joins us to discuss the company’s evolution into a more diversified and holistic wealth manager.Arnie unpacks the strategic shift beyond...
Navigating geopolitical turbulence:The strategic case for defence technology
With countries across the world committing more spend to their military, gaining exposure to the defence sector has increasingly become a key strategy for investors. As the escalating US-Iran conflict has been making headlines, this secto...
Weekly Wrap 27 March
In today’s Weekly Wrap episode, Will Riggall and Sophia Mavridis chat about the key insights heard at the ASX SMIDcaps conference this week, proudly sponsored by Bell Financial Group.Our CIO Will Riggall and Lead Strategist Rob Crooksto...
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
In this episode of From the Helm, Grady sits down with Summerset Group Holdings (ASX:SNZ) CFO Margaret Warrington to unpack their end-to-end business model for aged care sites, from land acquisition all the way through to building and operating...
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pan...
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive diseas...
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
In this episode of From the Helm, Grady sits down with Neuren Pharmaceuticals (ASX:NEU) CEO Jon Pilcher, to recap on their major developments over the last 12 months in the US market, their guidance looking ahead for next financial year, and th...
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
In this episode of From the Helm, Grady chats with Saluda Medical (ASX:SM1) President and CEO Barry Regan to discuss their recent developments since their IPO in November, their developmental drug for the treatment of chronic pain, and what is ...
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for...
From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu
In this episode of From the Helm, Grady sits down with Mesoblast Director Silviu Itescu, to unpack the recent approval and launch of their Ryoncil drug for children, their outlook for the next 12 months in capturing the adult market, and their ...
From the helm: 4DMedical (ASX:4DX), Founder & CEO, Andreas Fouras
In this episode of From the helm, Grady chats with 4D Medical (ASX:4DX) Founder and CEO Andreas Fouras to reflect on the meteoric rise of their lung imaging technology and detail their future plans for further global expansion.